Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Elsevier research will be featured at upcoming Safety Pharmacology Society meeting

Posted on September 4th, 2019 by in Pharma R&D

Network showing human adverse events that are concordant in one or more species (Source: Matthew Clark & Thomas Steiger-Hartmann, Regulatory Toxicology and Pharmacology, July 2018)

The 2019 Safety Pharmacology Society meeting will be in Barcelona from September 23-26, and the event is bringing together industry professionals to share best practices, enjoy networking opportunities, hear keynote speeches from thought leaders, and learn about hot research topics from experts in the field.

(more…)

Machine Learning Is Accelerating the Pace of Drug Development, But Good Data is Key

Posted on April 19th, 2019 by in Pharma R&D

Artificial Intelligence, Machine Learning and Deep Learning are on the tip of everyone’s tongues when it comes to acceleration of the pace of discovery The Pharma R&D market is a perfect exemplification of this phenomenon. Medical advancements enabled by such technologies have proven to significantly accelerate discovery processes, saving valuable time and money required for the development of life changing solutions. That being said, there is the reality that human beings with a passion and talent for feeding such mechanisms still and likely always will provide invaluable inputs. In short, we are not to be replaced by these advancements; rather the changes are indicative of a new era of advancement defined by “partnerships” between humans and machines.

(more…)

Government Shutdown Means New Drugs May Have to Wait – But Safety Monitoring Will Continue

Posted on January 17th, 2019 by in Pharma R&D

The partial shutdown of the U.S. government, which began just before the Christmas holiday, has been especially terrible for hundreds of thousands of federal employees who are either furloughed or working without pay. (more…)

Advances in Gene & Cell Therapy

Posted on November 6th, 2017 by in Pharma R&D

I would like to applaud the recent news about the Advisory Panel to the USA FDA’s unanimous (16-0) recommendation for allowing to further develop therapy by Spark Therapeutics Inc. (more…)

  1. 1
  2. 2